Search by Drug Name or NDC

    NDC 65862-0878-03 Solifenacin Succinate 5 mg/1 Details

    Solifenacin Succinate 5 mg/1

    Solifenacin Succinate is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is SOLIFENACIN SUCCINATE.

    Product Information

    NDC 65862-0878
    Product ID 65862-878_23e11677-e5e3-44a1-9de8-5e40a2c92200
    Associated GPIs
    GCN Sequence Number 057982
    GCN Sequence Number Description solifenacin succinate TABLET 5 MG ORAL
    HIC3 R1I
    HIC3 Description URINARY TRACT ANTISPASMODIC, M(3) SELECTIVE ANTAG.
    GCN 23276
    HICL Sequence Number 026595
    HICL Sequence Number Description SOLIFENACIN SUCCINATE
    Brand/Generic Generic
    Proprietary Name Solifenacin Succinate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Solifenacin Succinate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name SOLIFENACIN SUCCINATE
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206817
    Listing Certified Through 2024-12-31

    Package

    NDC 65862-0878-03 (65862087803)

    NDC Package Code 65862-878-03
    Billing NDC 65862087803
    Package 3 BLISTER PACK in 1 CARTON (65862-878-03) / 10 TABLET, FILM COATED in 1 BLISTER PACK (65862-878-10)
    Marketing Start Date 2022-12-27
    NDC Exclude Flag N
    Pricing Information N/A